A retrospective study of use of anti-TNF drugs in Patients With Inflammatory Bowel Diseases
Latest Information Update: 22 Dec 2020
Price :
$35 *
At a glance
- Drugs Adalimumab (Primary) ; Certolizumab pegol (Primary) ; Infliximab (Primary)
- Indications Inflammatory bowel diseases
- Focus Adverse reactions
- 22 Dec 2020 New trial record
- 28 Oct 2020 Results presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2020